Skip to main content
Erschienen in: Diabetologia 2/2009

01.02.2009 | Article

Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006

verfasst von: C.-H. Tseng, C.-K. Chong, T.-Y. Tai

Erschienen in: Diabetologia | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Studies have identified an association between diabetes and breast cancer in postmenopausal women in Western countries. Such an association needs to be confirmed in an Asian population. The aim of this study was to evaluate the secular trend for breast cancer mortality in Taiwanese women in the general population and the mortality rate ratios between diabetic patients and the general population.

Methods

Age-specific mortality rates for the general population, categorised into groups aged 25–54, 55–64, 65–74 and ≥75 years, were calculated for the years between 1995 and 2006 (inclusive) from vital statistics published by the Taiwanese government. Linear regression was used to test the trends. A total of 131,573 diabetic women aged ≥25 years from a national cohort recruited between 1995 and 1998 (inclusive) were followed prospectively for vital status, determined from the National Register of Deaths. Mortality rates and mortality rate ratios (mortality rate in diabetic women vs the average and highest mortality rates for the general population) were calculated.

Results

A total of 14,230 women aged ≥25 years in the general population died of breast cancer between 1995 and 2006. A trend for an increase in the annual rate was observed for all age groups. A total of 482 diabetic women died of breast cancer, with a crude mortality rate of 45.7 per 100,000 person-years. Compared with the general population the relative risk of mortality for those with diabetes ranged from 1.37 (for the group aged 55–64 years) to 2.43 (for the group aged 25–54 years).

Conclusions/interpretation

We identified a secular trend of an increase in the rate of breast cancer mortality in the Taiwanese general population. Our data suggest a higher risk of breast cancer mortality in diabetic patients in all age groups.
Literatur
1.
Zurück zum Zitat Freund E (1885) Zur diagnose des carcinoms. Wien Med B1:268–268 (in German) Freund E (1885) Zur diagnose des carcinoms. Wien Med B1:268–268 (in German)
2.
Zurück zum Zitat Xue F, Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86:823S–835S Xue F, Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86:823S–835S
3.
Zurück zum Zitat Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856–862PubMedCrossRef Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856–862PubMedCrossRef
4.
Zurück zum Zitat Muti P, Quattrin T, Grant BJ et al (2002) Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomark Prev 11:1361–1368 Muti P, Quattrin T, Grant BJ et al (2002) Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomark Prev 11:1361–1368
5.
Zurück zum Zitat Rapp K, Schroeder J, Klenk J et al (2006) Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 49:945–952PubMedCrossRef Rapp K, Schroeder J, Klenk J et al (2006) Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 49:945–952PubMedCrossRef
6.
Zurück zum Zitat Barclay AW, Petocz P, McMillan-Price J et al (2008) Glycemic index, glycemic load, and chronic disease risk—a meta-analysis of observational studies. Am J Clin Nutr 87:627–637PubMed Barclay AW, Petocz P, McMillan-Price J et al (2008) Glycemic index, glycemic load, and chronic disease risk—a meta-analysis of observational studies. Am J Clin Nutr 87:627–637PubMed
7.
Zurück zum Zitat Rollison DE, Giuliano AR, Sellers TA et al (2008) Population-based case–control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states. Am J Epidemiol 167:447–456PubMedCrossRef Rollison DE, Giuliano AR, Sellers TA et al (2008) Population-based case–control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states. Am J Epidemiol 167:447–456PubMedCrossRef
8.
Zurück zum Zitat Wu AH, Yu MC, Tseng CC, Stanczyk FZ, Pike MC (2007) Diabetes and risk of breast cancer in Asian-American women. Carcinogenesis 28:1561–1566PubMedCrossRef Wu AH, Yu MC, Tseng CC, Stanczyk FZ, Pike MC (2007) Diabetes and risk of breast cancer in Asian-American women. Carcinogenesis 28:1561–1566PubMedCrossRef
9.
Zurück zum Zitat Goodman MT, Cologne JB, Moriwaki H, Vaeth M, Mabuchi K (1997) Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. Prev Med 26:144–153PubMedCrossRef Goodman MT, Cologne JB, Moriwaki H, Vaeth M, Mabuchi K (1997) Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. Prev Med 26:144–153PubMedCrossRef
10.
Zurück zum Zitat Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293:194–202PubMedCrossRef Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293:194–202PubMedCrossRef
11.
Zurück zum Zitat Khan M, Mori M, Fujino Y, Japan Collaborative Cohort Study Group et al (2006) Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev 7:253–259PubMed Khan M, Mori M, Fujino Y, Japan Collaborative Cohort Study Group et al (2006) Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev 7:253–259PubMed
12.
Zurück zum Zitat Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166:1871–1877PubMedCrossRef Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166:1871–1877PubMedCrossRef
13.
Zurück zum Zitat Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160–1167PubMedCrossRef Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160–1167PubMedCrossRef
14.
Zurück zum Zitat Verlato G, Zoppini G, Bonora E, Muggeo M (2003) Mortality from site-specific malignancies in type 2 diabetic patients from Verona. Diabetes Care 26:1047–1051PubMedCrossRef Verlato G, Zoppini G, Bonora E, Muggeo M (2003) Mortality from site-specific malignancies in type 2 diabetic patients from Verona. Diabetes Care 26:1047–1051PubMedCrossRef
15.
Zurück zum Zitat Swerdlow AJ, Laing SP, Qiao Z et al (2005) Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 92:2070–2075PubMedCrossRef Swerdlow AJ, Laing SP, Qiao Z et al (2005) Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 92:2070–2075PubMedCrossRef
16.
Zurück zum Zitat Tseng CH (2004) Mortality and causes of death in a national sample of diabetic patients in Taiwan. Diabetes Care 27:1605–1609PubMedCrossRef Tseng CH (2004) Mortality and causes of death in a national sample of diabetic patients in Taiwan. Diabetes Care 27:1605–1609PubMedCrossRef
17.
Zurück zum Zitat Tseng CH (2006) Prevalence of lower-extremity amputation among patients with diabetes mellitus: Is height a factor? CMAJ 174:319–323PubMed Tseng CH (2006) Prevalence of lower-extremity amputation among patients with diabetes mellitus: Is height a factor? CMAJ 174:319–323PubMed
18.
Zurück zum Zitat Tseng CH (2006) Exogenous insulin use and hypertension in adult patients with type 2 diabetes mellitus. Arch Intern Med 166:1184–1189PubMedCrossRef Tseng CH (2006) Exogenous insulin use and hypertension in adult patients with type 2 diabetes mellitus. Arch Intern Med 166:1184–1189PubMedCrossRef
19.
Zurück zum Zitat Tseng CH, Tseng CP, Chong CK et al (2006) Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 49:1755–1760PubMedCrossRef Tseng CH, Tseng CP, Chong CK et al (2006) Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 49:1755–1760PubMedCrossRef
20.
Zurück zum Zitat Tseng CH (2007) Parental history of hypertension and diabetes and prevalence of hypertension in type 2 diabetic patients: A study of a national sample in Taiwan. Eur J Clin Invest 37:870–877PubMedCrossRef Tseng CH (2007) Parental history of hypertension and diabetes and prevalence of hypertension in type 2 diabetic patients: A study of a national sample in Taiwan. Eur J Clin Invest 37:870–877PubMedCrossRef
21.
Zurück zum Zitat American Cancer Society (2006) Breast cancer facts and figures 2005–2006. American Cancer Society, Atlanta American Cancer Society (2006) Breast cancer facts and figures 2005–2006. American Cancer Society, Atlanta
22.
Zurück zum Zitat Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6:103–111PubMedCrossRef Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6:103–111PubMedCrossRef
23.
Zurück zum Zitat Vona-Davis L, Howard-McNatt M, Rose DP (2007) Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev 8:395–408PubMedCrossRef Vona-Davis L, Howard-McNatt M, Rose DP (2007) Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev 8:395–408PubMedCrossRef
24.
Zurück zum Zitat Wolf I, Sadetzki S, Gluck I et al (2006) Association between diabetes mellitus and adverse characteristics of breast cancer at presentation. Eur J Cancer 42:1077–1082PubMedCrossRef Wolf I, Sadetzki S, Gluck I et al (2006) Association between diabetes mellitus and adverse characteristics of breast cancer at presentation. Eur J Cancer 42:1077–1082PubMedCrossRef
25.
Zurück zum Zitat Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285:885–892PubMedCrossRef Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285:885–892PubMedCrossRef
26.
Zurück zum Zitat Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M (2006) Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res 66:10269–10273PubMedCrossRef Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M (2006) Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res 66:10269–10273PubMedCrossRef
27.
Zurück zum Zitat Dowling RJ, Zakikhani M, Fantus IG, Pollak M, Sonenberg N (2007) Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res 67:10804–10812PubMedCrossRef Dowling RJ, Zakikhani M, Fantus IG, Pollak M, Sonenberg N (2007) Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res 67:10804–10812PubMedCrossRef
Metadaten
Titel
Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006
verfasst von
C.-H. Tseng
C.-K. Chong
T.-Y. Tai
Publikationsdatum
01.02.2009
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 2/2009
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1204-8

Weitere Artikel der Ausgabe 2/2009

Diabetologia 2/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.